24/7 Patient Assistance: 760-405-8205

Ari Baron, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. Ari Baron graduated the medical school from the Tufts University School of Medicine and completed his internship at the UCSF. He is both specialized and board certified in medical oncology. Dr. Baron has been in practice for more than 20 years and is affiliated with the San Francisco General Hospital and the California Pacific Medical Center. During his career, he has run several clinical trials and has also contributed to four publications of medical interest.



  • Education & Training

    dept_icon

    Tufts University

    Medical School

    dept_icon

    UCSF

    Internship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    California Pacific Medical Center

    Languages: English/Spanish

    (415) 600-6000

    Castro St & Duboce Ave

    San Francisco, California 94114

    Read More

    California Pacific Medical Center: Davies Campus

    Languages: English/Spanish

    (415) 600-6000

    Castro St & Duboce Ave

    San Francisco, California 94114

    Read More

    San Francisco General Hospital

    Languages: English/Spanish

    (415) 206-8000

    1001 Potrero Ave

    San Francisco, California 94110

    Read More
  • Publications & Memberships

    Dr. Ari Baron has contributed to 3 publications.

    Lenalidomide and rituximab in Waldenstrom's macroglobulinemia.

    Treon, S.P., Soumerai, J.D., Branagan, A.R., Hunter, Z.R., Patterson, C.J., Ioakimidis, L., Chu, L., Musto, P., Baron, A.D., Nunnink, J.C., Kash, J.J., Terjanian, T.O....; Clin Cancer Res. 2009-01-01.

    See more >>

    Trastuzumab plus vinorelbine or taxane chemotherapy for HER2-overexpressing metastatic breast cancer: the trastuzumab and vinorelbine or taxane study.

    Burstein, H.J., Keshaviah, A., Baron, A.D., Hart, R.D., Lambert-Falls, R., Marcom, P.K., Gelman, R., Winer, E.P.; Cancer. 2007 Sep 1.

    See more >>

    A randomized, multicenter study to determine the safety and efficacy of the immunoconjugate SGN-15 plus docetaxel for the treatment of non-small cell lung carcinoma.

    Ross, H. J., Hart, L. L., Swanson, P. M., Rarick, M. U., Figlin, R. A., Jacobs, A. D., McCune, D. E., Rosenberg, A. H., Baron, A. D., Grove, L. E., Thorn, M. D., Mille...; Lung Cancer. 2006 Oct.

    See more >>

    Memberships

    American Society of Clinical Oncology

Verified Patient Reviews

Rate This Doctor

May 30, 2011

by Katherine P

Wait Time

Staff

Helpfulness

Knowledge

“Excellent bedside manner, he took his time with me and I never felt rushed. I would totally recommend him.”

August 03, 2007

by Alice B

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Baron is always a pleasant person to have around you. He takes the time with his patients and answers any question. ”